FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Eugia US Tobramycin for Injection Recall

Tobramycin for Injection, USP, 1

Eugia US LLC · East Windsor, NJ

Risk level
Class II
Reported by FDA
Mar 20, 2024
Recall ID
D-0385-2024
Check your lot numberHow we source this data

Summary

Eugia US recalled Tobramycin for Injection starting Feb 22, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0385-2024 on Mar 20, 2024. Reason: Failed Stability Specification: Water determination was found not complying with specification. Status: Terminated.

Why it was recalled

Failed Stability Specification: Water determination was found not complying with specification.

Product description

Tobramycin for Injection, USP, 1.2 grams per Pharmacy Bulk Package, Rx Only, For Intravenous Use, PHARMACY BULK PACKAGE NOT FOR DIRECT INFUSION, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, Carton NDC 55150-470-06, Vial NDC 55150-470-01.

Lot numbers, UPCs & expiration codes

Lot #s: 3TB23001, 3TB23002, Exp. 04/30/2025.

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0385-2024
Classification
Class II
Status
Terminated
Recall initiated
Feb 22, 2024
FDA report date
Mar 20, 2024
Quantity
1160 VIALS
Recall type
Voluntary: Firm initiated
Recalling firm
Eugia US LLC

Original FDA data

Every field from FDA enforcement report D-0385-2024, exactly as published.

Show all FDA fields
City
East Windsor
State
NJ
Status
Terminated
Country
United States
Event ID
94081
Address
279 Princeton Hightstown Rd
Code information
Lot #s: 3TB23001, 3TB23002, Exp. 04/30/2025.
Postal code
08520-1401
Report date
Mar 20, 2024
Product type
Drugs
Recall number
D-0385-2024
Classification
Class II
Recalling firm
Eugia US LLC
Product quantity
1160 VIALS
Termination date
Dec 22, 2025
Reason for recall
Failed Stability Specification: Water determination was found not complying with specification.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Tobramycin for Injection, USP, 1.2 grams per Pharmacy Bulk Package, Rx Only, For Intravenous Use, PHARMACY BULK PACKAGE NOT FOR DIRECT INFUSION, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, Carton NDC 55150-470-06, Vial NDC 55150-470-01.
Distribution pattern
Nationwide
Recall initiation date
Feb 22, 2024
Initial firm notification
Letter
Center classification date
Mar 14, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0385-2024, published Mar 20, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls